Sign in

CIK 0001401667 · Accelerated filer<br>Smaller reporting company

PUMA BIOTECHNOLOGY, INC.

Sign in to watch
Ticker
PBYI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770683487
Phone
(424) 248-6500
Business address
10880 WILSHIRE BLVD., SUITE 1700, LOS ANGELES, CA
Former names
INNOVATIVE ACQUISITIONS CORP
  1. 4 Planned sale Chief Commercial Officer sold 12,103 shares at $3.31 ($40,075)
  2. 4 Planned sale See Remarks sold 7,809 shares at $3.31 ($25,857)
  3. 4 Planned sale President and CEO sold 60,698 shares at $3.31 ($200,983)
  4. 4 Planned sale Director sold 27,000 shares at $3.45 ($93,269)
  5. 4 Planned sale Director sold 22,000 shares at $3.45 ($75,970)
  6. 4 Planned sale Director sold 9,900 shares at $3.46 ($34,252)
  7. 4 Planned sale Director sold 27,000 shares at $3.45 ($93,280)
  8. 4 Planned sale Director sold 10,000 shares at $3.45 ($34,500)
  9. 4 Planned sale Director sold 13,500 shares at $3.45 ($46,630)
  10. 4 Grant or award Director acquired 27,000 shares (grant or award)
  11. 4 Planned sale Chief Scientific Officer sold 269 shares at $3.45 ($928)
  12. 4 Grant or award Chief Scientific Officer acquired 58,601 shares (grant or award)
  13. 4 Grant or award Chief Financial Officer acquired 58,601 shares (grant or award)
  14. 4 Grant or award Chief Commercial Officer acquired 66,972 shares (grant or award)
  15. 4 Grant or award See Remarks acquired 48,136 shares (grant or award)
  16. 4 Grant or award President and CEO acquired 186,403 shares (grant or award)
  17. 4 Open-market sale Chief Scientific Officer sold 3,460 shares at $4.18 ($14,456)
  18. 4 Open-market sale Chief Financial Officer sold 10,499 shares at $4.18 ($43,864)
  19. 4 Open-market sale Chief Commercial Officer sold 6,568 shares at $4.18 ($27,440)
  20. 4 Open-market sale See Remarks sold 4,225 shares at $4.18 ($17,652)

Page 5 of 24 · 471 filings